These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9076645)

  • 21. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report.
    Cohen LS; Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL
    Am J Psychiatry; 2003 Aug; 160(8):1519-22. PubMed ID: 12900318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Motives for initiation, temporary discontinuation, and permanent discontinuation of hormone replacement therapy use among Norwegian women.
    Øren A
    Maturitas; 2009 Sep; 64(1):33-7. PubMed ID: 19720480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women.
    Wihlbäck AC; Nyberg S; Bäckström T; Bixo M; Sundström-Poromaa I
    Psychoneuroendocrinology; 2005 Jan; 30(1):38-50. PubMed ID: 15358441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women.
    Matthews KA; Wing RR; Kuller LH; Meilahn EN; Kelsey SF; Costello EJ; Caggiula AW
    J Consult Clin Psychol; 1990 Jun; 58(3):345-51. PubMed ID: 2365898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of estrogen replacement therapy on symptoms of depression and anxiety in non-depressive menopausal women: a randomized double-blind, controlled study.
    Demetrio FN; Rennó J; Gianfaldoni A; Gonçalves M; Halbe HW; Filho AH; Gorenstein C
    Arch Womens Ment Health; 2011 Dec; 14(6):479-86. PubMed ID: 22016254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 May; 5(5):419-45. PubMed ID: 10147233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A psychological analysis of menopausal hot flushes.
    Hunter MS; Liao KL
    Br J Clin Psychol; 1995 Nov; 34(4):589-99. PubMed ID: 8563666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of surgical menopause on psychological characteristics and lipid levels: the Healthy Women Study.
    Everson SA; Matthews KA; Guzick DS; Wing RR; Kuller LH
    Health Psychol; 1995 Sep; 14(5):435-43. PubMed ID: 7498115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women.
    Castelo-Branco C; Peralta S; Ferrer J; Palacios S; Cornago S; Quereda F
    Climacteric; 2006 Oct; 9(5):380-7. PubMed ID: 17000585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Women's anticipations of hormonal replacement therapy.
    Wardell DW; Engebretson JC
    Maturitas; 1995 Nov; 22(3):177-83. PubMed ID: 8746874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of 25 mg and 50 mg oestradiol implants in the control of climacteric symptoms following hysterectomy and bilateral salpingo-oophorectomy.
    Panay N; Versi E; Savvas M
    BJOG; 2000 Aug; 107(8):1012-6. PubMed ID: 10955434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An audit of oestradiol levels and implant frequency in women undergoing subcutaneous implant therapy.
    Buckler HM; Kalsi PK; Cantrill JA; Anderson DC
    Clin Endocrinol (Oxf); 1995 May; 42(5):445-50. PubMed ID: 7621560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of premenopausal hormones on severity of climacteric symptoms and use of HRT.
    Fentiman IS; Allen D; Wheeler M; Rymer J
    Climacteric; 2006 Apr; 9(2):135-45. PubMed ID: 16698660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, placebo-controlled, crossover study on the effect of oral oestradiol on acute menopausal symptoms.
    Chung TK; Yip SK; Lam P; Chang AM; Haines CJ
    Maturitas; 1996 Oct; 25(2):115-23. PubMed ID: 8905602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlates of hormone replacement therapy use in Italian women, 1992-1996.
    Chiaffarino F; Parazzini F; La Vecchia C; Bianchi MM; Benzi G; Ricci E; Chiantera V
    Maturitas; 1999 Oct; 33(2):107-15. PubMed ID: 10597874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
    Moorhead T; Hannaford P; Warskyj M
    Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alleviation of the climacteric symptoms with oral sequential hormone replacement therapy.
    Chittacharoen A; Domhardt R; Manonai J; Theppisai U; Golbs S
    J Med Assoc Thai; 2004 Jan; 87(1):1-7. PubMed ID: 14971528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis and evaluation of climacteric symptoms. The "Menopause Rating Scale" MRS helps in diagnosis and evaluation of therapeutic effectiveness].
    Hauser GA
    Fortschr Med; 1996 Feb; 114(5):49-52. PubMed ID: 8867476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-response and withdrawal effects on climacteric symptoms after hormonal replacement therapy. A placebo-controlled therapeutic trial.
    Jensen J; Christiansen C
    Maturitas; 1983 Aug; 5(2):125-33. PubMed ID: 6415364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of treatment choice for menopausal hot flushes: hormonal versus psychological versus no treatment.
    Hunter MS; Liao KL
    J Psychosom Obstet Gynaecol; 1995 Jun; 16(2):101-8. PubMed ID: 7640722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.